JCI vs PETS · P/E 44, rev $23.60B vs rev $179.0M
Johnson Controls International PLC (JCI) versus PetMed Express Inc (PETS) — a side-by-side from cached financials, not a winner call.
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
PetMed Express Inc (PETS) is a pharmaceutical retailers company listed on NASDAQ.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
Latest reported PETS revenue for 2026-03-31 was $179.0M. Net income was -$57.3M. Revenue was down 21.1% from 2025-03-31 to 2026-03-31. PETS currently screens at market cap $38.5M.
JCI currently screens at market cap $87.62B and trailing P/E 43.9. PETS currently screens at market cap $38.5M.
Not investment advice. Open the JCI and PETS stock pages for the full models.
Not investment advice.